Veru Announces Acceptance of Two Abstracts for Presentation at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

NEXT STORY
Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer
PREV STORY
United States COVID-19 Vaccines and Therapeutics Market Tracker: Q2, 2021 Report – Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Data From SELLAS Life Sciences’ Positive Phase 2 Acute Myeloid Leukemia Study Published in American Society of Hematology’s Journal, Blood Advances

NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq:SLS) ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials

FIT Biotech Oy                                                                                                                                                                                                           Press release 27.8.2018 at 08.30 AM EET FIT Biotech ...

author_avatar
NASDAQ Market News

Myriad Genetics Receives Additional Reimbursement for myChoice® Diagnostic System in Japan

author_avatar
NASDAQ Market News